Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report

Abstract Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not...

Full description

Bibliographic Details
Main Authors: Minoo Moghimi, Zahra Nekoukar, Farhad Gholami
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.5161
_version_ 1818975604145389568
author Minoo Moghimi
Zahra Nekoukar
Farhad Gholami
author_facet Minoo Moghimi
Zahra Nekoukar
Farhad Gholami
author_sort Minoo Moghimi
collection DOAJ
description Abstract Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been reported before.
first_indexed 2024-12-20T15:58:35Z
format Article
id doaj.art-18392f45ad8b415a831e754eef1022f9
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-12-20T15:58:35Z
publishDate 2021-12-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-18392f45ad8b415a831e754eef1022f92022-12-21T19:34:22ZengWileyClinical Case Reports2050-09042021-12-01912n/an/a10.1002/ccr3.5161Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case reportMinoo Moghimi0Zahra Nekoukar1Farhad Gholami2Department of Clinical Pharmacy Mazandaran University of Medical Sciences Sari IranDepartment of Clinical Pharmacy Mazandaran University of Medical Sciences Sari IranDepartment of Internal Medicine Faculty of Medicine Mazandaran University of Medical Sciences Mazandaran IranAbstract Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66‐year‐old male MGN case treated with MMF and revealed acquired sensory‐motor axonal polyneuropathy, which is rare and has not been reported before.https://doi.org/10.1002/ccr3.5161membranous glomerulonephropathymycophenolate mofetilperipheral neuropathy
spellingShingle Minoo Moghimi
Zahra Nekoukar
Farhad Gholami
Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
Clinical Case Reports
membranous glomerulonephropathy
mycophenolate mofetil
peripheral neuropathy
title Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_full Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_fullStr Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_full_unstemmed Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_short Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
title_sort mycophenolate mofetil induced peripheral neuropathy in the treatment of membranous glomerulonephropathy a case report
topic membranous glomerulonephropathy
mycophenolate mofetil
peripheral neuropathy
url https://doi.org/10.1002/ccr3.5161
work_keys_str_mv AT minoomoghimi mycophenolatemofetilinducedperipheralneuropathyinthetreatmentofmembranousglomerulonephropathyacasereport
AT zahranekoukar mycophenolatemofetilinducedperipheralneuropathyinthetreatmentofmembranousglomerulonephropathyacasereport
AT farhadgholami mycophenolatemofetilinducedperipheralneuropathyinthetreatmentofmembranousglomerulonephropathyacasereport